• Contact us
  • International Headquarters
  • Adverse reactions - Pharmacovigilance
  • Grifols Ethics Line
  • Change Language
  • Español
  • Deutsch
  • 中文
'Grifols.com' logo 'Grifols.com' logo

  • Company

    Since 1909, Grifols has worked to improve the health and well-being of people around the world.

    Read more
    • What We Do 
      • Biopharma
      • Diagnostic
      • Bio Supplies
      • Healthcare Solutions for Hospitals
    • Leadership 
    • Mission, vision and values 
    • Ethics and Compliance 
    • Our History 
    • Grifols Museum 
      • La Casa: Where It All Began
      • The Plant: People Helping People
      • The World: From Family Business to Global Company
    • Grifology 
      • The Cabinet
    • Grifols Engineering 
    Every action we take is motivated by our mission to improve people's lives. 
    Our unique and remarkable history combines scientific expertise with a desire to serve patients and society. 
    We develop, produce and market innovative medicines, solutions and services in more than 110 countries. 

  • Innovation

    Grifols is full speed ahead on developing the next innovative breakthroughs across multiple therapeutic areas.  

    Read more
    • Plasma Powerhouse 
    • Beyond Plasma 
    • Key Therapeutic Areas 
      • Immunology
      • Hepatology and Intensive Care
      • Pulmonology
      • Hematology
      • Neurology
      • Infectious Diseases
      • Further Therapeutic Opportunities
    • CHRONOS-PD: Plasma Science in Parkinson’s Research 
    • Extending Our Innovative Reach 
      • Team Up with Grifols Innovation and New Technologies
      • Scientific Awards and Programs
    • Connecting Knowledge - Our R&D Network 
    We apply our growing knowledge of plasma to change healthcare. 
    Our treatments are enhancing people’s well-being and quality of life. 
    We’re drawing on a broad scientific base to continue innovating. 

  • Sustainability

    Grifols' longstanding commitment to people and the planet entails helping society on all fronts.

    Read more
    • Commitment to Donors and Patients 
      • Supporting Donors
      • Supporting Patients
    • Impact on Society 
      • Our Foundations
    • Our People 
    • The Environment 
    • Ethical Leadership 
    • Sustainability Reports 
    2024 Integrated and Sustainability Annual Report 
    Patients drive the work we do every day. We support patients and patient associations. 
    As mindful stewards of the environment we are resolved to fight climate change. 
  • Products

  • Investors

    Read more

    • Stock Information

      • Stock and share capital
      • Dividends
      • Major Holders and Treasury Stock
      • Agreements between Shareholders
      • Analyst Coverage

    • Financials

      • Financial Results
      • Annual Accounts
      • Fixed Income and Credit Ratings
      • Average Period of Payment to Suppliers
      • Key Figures
    • Press Releases 
    • Presentations and Events 
    • Agenda 

    • Communications with CNMV and SEC

      • CNMV
      • SEC
      • Other Relevant Information
      • Inside Information
      • Significant events until 8 February 2020
    • Corporate Stewardship Reports 

    • Corporate Governance

      • Board of Directors
      • General Shareholders’ Meeting
      • Annual Corporate Governance Report
      • Directors' Remuneration Report
      • Articles of Association
      • Corporate Policies
    • Mergers 
    • Biotest: Voluntary Takeover Offer | Freiwilliges Übernahmeangebot (2021) 
    • Biotest: Acquisition offer (delisting) / freiwilliges Erwerbsangebot (Delisting) (2025) 
    Presentation First Quarter 2025 Results 
    2024 Integrated and Sustainability Annual Report 
    2025 Investor and Analyst meeting - webcast 

  • Careers

    People are at the heart of our business. We are committed to continued investment in training and development.

    Explore Opportunities
    • Why Grifols 
      • People & Culture
      • Our teams
    • Training and Development 
    • Hiring Journey 
    • Early Careers 

  • Media

    Latest news about the company and contact information for journalists and communication professionals.

    Read more
    • Newsroom 
    • Events 
      • Q1 2025 Financial Results
    • Media Contacts 
    • Media Center 

  • Partners

    At Grifols, we believe in long-term, mutually trusting relationships with our partners.

    More details
    • Join our network of suppliers 
  • Change Language
  • Español
  • Deutsch
  • 中文
  • Company
    • Company
    • What We Do
      • What We Do
      • Biopharma
      • Diagnostic
      • Bio Supplies
      • Healthcare Solutions for Hospitals
    • Leadership
    • Mission, vision and values
    • Ethics and Compliance
    • Our History
    • Grifols Museum
      • Grifols Museum
      • La Casa: Where It All Began
      • The Plant: People Helping People
      • The World: From Family Business to Global Company
    • Grifology
      • Grifology
      • The Cabinet
    • Grifols Engineering
  • Innovation
    • Innovation
    • Plasma Powerhouse
    • Beyond Plasma
    • Key Therapeutic Areas
      • Key Therapeutic Areas
      • Immunology
      • Hepatology and Intensive Care
      • Pulmonology
      • Hematology
      • Neurology
      • Infectious Diseases
      • Further Therapeutic Opportunities
    • CHRONOS-PD: Plasma Science in Parkinson’s Research
    • Extending Our Innovative Reach
      • Extending Our Innovative Reach
      • Team Up with Grifols Innovation and New Technologies
      • Scientific Awards and Programs
    • Connecting Knowledge - Our R&D Network
  • Sustainability
    • Sustainability
    • Commitment to Donors and Patients
      • Commitment to Donors and Patients
      • Supporting Donors
      • Supporting Patients
    • Impact on Society
      • Impact on Society
      • Our Foundations
    • Our People
    • The Environment
    • Ethical Leadership
    • Sustainability Reports
  • Products
  • Investors
    • Investors
    • Stock Information
      • Stock and share capital
      • Dividends
      • Major Holders and Treasury Stock
      • Agreements between Shareholders
      • Analyst Coverage
    • Financials
      • Financial Results
      • Annual Accounts
      • Fixed Income and Credit Ratings
      • Average Period of Payment to Suppliers
      • Key Figures
    • Press Releases
    • Presentations and Events
    • Agenda
    • Communications with CNMV and SEC
      • CNMV
      • SEC
      • Other Relevant Information
      • Inside Information
      • Significant events until 8 February 2020
    • Corporate Stewardship Reports
    • Corporate Governance
      • Board of Directors
      • General Shareholders’ Meeting
      • Annual Corporate Governance Report
      • Directors' Remuneration Report
      • Articles of Association
      • Corporate Policies
    • Mergers
    • Biotest: Voluntary Takeover Offer | Freiwilliges Übernahmeangebot (2021)
    • Biotest: Acquisition offer (delisting) / freiwilliges Erwerbsangebot (Delisting) (2025)
  • Careers
    • Careers
    • Why Grifols
      • Why Grifols
      • People & Culture
      • Our teams
    • Training and Development
    • Hiring Journey
    • Early Careers
  • Media
    • Media
    • Newsroom
    • Events
      • Events
      • Q1 2025 Financial Results
    • Media Contacts
    • Media Center
  • Partners
    • Partners
    • Join our network of suppliers

Connect with us

Investors
Grifols Investors Stock Information Analyst Coverage

Analyst Coverage

 

The information contained on the Grifols worldwide website is not applicable to all countries. For specific information on the products and services available in your country, please select your country from the list included in the corresponding section. The purpose of this website is to provide information about Grifols' products and services, and it is not intended for, nor may it be construed as, promoting any products in countries in which they are not approved.

'Grifols.com' logo 'Grifols.com' logo

About Us

About Us

  • Company
  • Sustainability
  • Innovation
  • Products
  • Investors
  • Careers
  • Media

Top websites

Top websites

  • Grifols Plasma
  • Grifols Diagnostics Solutions
  • Grifols Scientific Awards
  • Grifols Engineering
  • Grifols Egypt for Plasma Derivatives
  • Victor Grifols i Lucas Foundation
  • Probitas Foundation
  • J.A. Grifols Foundation

Legal & Help

Legal & Help

  • Privacy Notices
  • Cookies Policy
  • Cookies Settings
  • Terms of Use
  • Contact
  • Glossary

Connect with us

© 2025 Grifols, S.A. All rights reserved worldwide.